Why O-Negative Blood Is in Constant Demand
Updated May 2026
Reference summary
Only 6.6 percent of US donors are O-negative, but it is the only red cell that any patient can receive in an emergency. Every trauma bay, every emergency department, every operating room, and every neonatal unit reserves O-negative for patients whose type has not been determined. The result is chronic supply pressure. This page explains the supply-demand mismatch and the practical implications for O-negative donors. It is not medical advice.
The 6.6 percent that supplies almost everyone
The American Red Cross blood types page publishes the US donor distribution: 37.4 percent O-positive, 35.7 percent A-positive, 8.5 percent B-positive, 6.6 percent O-negative, 6.3 percent A-negative, 3.4 percent AB-positive, 1.5 percent B-negative, 0.6 percent AB-negative. The 6.6 percent O-negative share has remained stable for decades.
What the donor distribution does not show is the demand profile. Trauma protocols, mass casualty plans, and neonatal transfusion algorithms all start with O-negative. The patient population that receives O-negative red cells is much larger than the 6.6 percent of patients who actually have type O-negative. This is why O-negative is described as the universal donor and why it is the chronic supply pressure point in modern blood banking.
The NHSBT O-negative page describes the same dynamic for UK patients. Both blood services run targeted O-negative recruitment programmes year-round.
Where O-negative is used
Trauma resuscitation. A patient arriving in haemorrhagic shock cannot wait for blood typing (which takes 5 to 30 minutes for an emergency type-and-screen, longer for full crossmatch). Modern trauma protocols call for immediate O-negative red cells and AB plasma in the first wave, transitioning to type-specific products once the type is known. The doctrine traces to military trauma care and has been adopted in civilian Level 1 trauma centres worldwide.
Neonatal transfusion. Sick newborns who need transfusion may not have a determined ABO/Rh type at the moment of need. Their immune systems are immature, and the safest default is O-negative. The UK JPAC transfusion guidelines codify this practice.
Mass casualty events. Major incidents (transport disasters, terror attacks, natural disasters) can produce dozens to hundreds of casualties simultaneously. The first responding medical teams use O-negative until the casualty load is triaged and typed. National blood services hold strategic O-negative stocks specifically for these scenarios.
Sickle cell disease and chronic transfusion. Patients on chronic red cell transfusion (sickle cell, thalassaemia, some bone marrow failure conditions) often receive antigen-matched units beyond simple ABO/Rh, which increases the proportion of O-negative-compatible donors needed. The American Red Cross Sickle Cell programme and similar UK programmes recruit specifically for the donor profile that supports these patients.
Rh-negative women of childbearing potential. Even outside emergencies, the principle of avoiding Rh sensitisation in young women shapes some routine transfusion practice. Where supply allows, Rh-negative women receive Rh-negative blood. See our Rh factor pregnancy page for the clinical rationale.
Demand vs supply: the chronic mismatch
The Red Cross has reported that O-negative is requested in roughly 17 percent of red cell orders despite making up only 6.6 percent of donors. The numbers vary by hospital and by season but the pattern is consistent: demand outstrips supply share by a factor of two to three.
The mismatch has structural causes. The trauma and emergency-medicine doctrine that calls for O-negative as the default emergency product is unlikely to change; alternative products (frozen blood, lab-typed group O whole blood, future cell-cultured red cells) are not yet ready to displace O-negative in routine use. The 6.6 percent population share of O-negative is fixed by genetics and will not change. The result is an open-ended supply gap that has to be managed through donor recruitment.
Cell-cultured red blood cells from stem cell sources are in early-phase clinical trials in the UK (the University of Bristol RESTORE trial) and may eventually offer a manufactured O-negative source for patients with rare blood types. They are not yet available at scale.
If you are O-negative: how to help most
Donate as often as eligible. Whole blood every 56 days (US) or 12 to 16 weeks (UK) is the baseline. Power Red (US Red Cross apheresis double red cell donation) collects two units of red cells per visit and is particularly valuable for O-negative donors; the longer interval (112 days) suits donors who can commit to fewer visits per year.
Sign up for automated appointment reminders. The Red Cross app and the NHSBT booking system both send notifications when you become eligible again. Regular O-negative donors who keep to a 6 or 8 week schedule contribute several units a year, far more than the average donor.
Maintain iron stores. Frequent donation depletes iron faster than it is replenished from average diets. The Red Cross Iron-Replacement Programme mails iron supplements to donors who give frequently. NHSBT publishes iron-rich-food guidance for donors. A daily oral iron supplement during periods of regular donation is a simple way to keep haemoglobin above the deferral threshold.
Consider joining the relevant rare-donor programme if you have rare antigens beyond the basic O-negative status. The UK Red Cross works with NHSBT's International Blood Group Reference Laboratory; the US has the American Rare Donor Program. These registers connect donors with rare antigens (Vel-negative, U-negative, Rh-D variants) to patients worldwide.
Why O-positive donors still matter
O-positive donors are not the universal donor, but they are the next-best option for many patients. Hospitals routinely transfuse O-positive red cells to male patients and to post-menopausal women whose Rh-D status is unknown, because Rh sensitisation is only a concern in women who could become pregnant. This stretches O-negative supply for the patients who genuinely need it.
O-positive is the most common type at 37 percent of donors and supports the largest proportion of patients in routine practice. See our O-positive blood type page for the donor profile and compatibility.
The whole donor pool matters for whole-blood supply. A and B donors support the much larger A and B recipient populations. AB donors support the much smaller AB population for red cells but contribute hugely to the plasma supply (see plasma compatibility). No donor type is dispensable; O-negative is just the chronic pressure point.
Frequently asked questions
What percentage of donors are O-negative?
Why is O-negative blood always needed?
How can O-negative donors help most?
Are there other rare blood types in chronic demand?
Does O-negative blood expire?
What happens if O-negative blood runs out?
Is O-negative the most-needed blood type overall by volume?
Find a donation centre near you
US: American Red Cross find-a-drive tool. UK: NHSBT donation booking. Both let you search by postcode or zip code, see current local need, and book an appointment online.